TACHYCARDIA SENSING FAILURE OF AN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IN A PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY

被引:1
作者
GRUBB, BP [1 ]
DURZINSKY, D [1 ]
TEMESYARMOS, P [1 ]
HAHN, H [1 ]
ELLIOTT, L [1 ]
机构
[1] MED COLL OHIO,DIV CARDIOTHORAC SURG,TOLEDO,OH 43699
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 1992年 / 15卷 / 06期
关键词
HYPERTROPHIC CARDIOMYOPATHY; IMPLANTABLE DEFIBRILLATOR;
D O I
10.1111/j.1540-8159.1992.tb03072.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 17-year-old white male was found to have nonobstructive hypertrophic cardiomyopathy after suffering three severe syncopal episodes. He experienced an episode of sustained polymorphic ventricular tachycardia during exercise tolerance testing that required cardioversion. Electrophysiological studies were able to reproduce sustained polymorphic ventricular tachycardia that was unresponsive to standard pharmacotherapy. An automatic implantable defibrillator was placed. However, during implantation with the rate sensing electrodes on the left ventricle, it was found that the extremely polymorphic nature of the tachycardia caused such rapid fluctuations in the sensed R wave signal that the device could not properly detect the tachycardia. This was felt to be due to the automatic gain control circuit of the Ventak 1550. The problem was solved by moving the rate sensing electrodes to the lateral right ventricle. This case suggests that the unique arrhythmic substrate of hypertrophic cardiomyopathy may present sensing difficulties during automatic implantable defibrillator insertion.
引用
收藏
页码:845 / 848
页数:4
相关论文
共 11 条
[1]  
Bonow R O, 1988, Cardiovasc Clin, V19, P221
[2]   IMPLANTATION OF THE AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (AICD) - PRACTICAL ASPECTS [J].
CANNOM, DS ;
WINKLE, RA .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1986, 9 (06) :793-809
[3]   ELECTROPHYSIOLOGIC ABNORMALITIES IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY - A CONSECUTIVE ANALYSIS IN 155 PATIENTS [J].
FANANAPAZIR, L ;
TRACY, CM ;
LEON, MB ;
WINKLER, JB ;
CANNON, RO ;
BONOW, RO ;
MARON, BJ ;
EPSTEIN, SE .
CIRCULATION, 1989, 80 (05) :1259-1268
[4]   HYPERTROPHIC CARDIOMYOPATHY - INTERRELATIONS OF CLINICAL MANIFESTATIONS, PATHOPHYSIOLOGY, AND THERAPY .1. [J].
MARON, BJ ;
BONOW, RO ;
CANNON, RO ;
LEON, MB ;
EPSTEIN, SE .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (13) :780-789
[5]   SUDDEN-DEATH IN HYPERTROPHIC CARDIOMYOPATHY - A PROFILE OF 78 PATIENTS [J].
MARON, BJ ;
ROBERTS, WC ;
EPSTEIN, SE .
CIRCULATION, 1982, 65 (07) :1388-1394
[6]   HYPERTROPHIC CARDIOMYOPATHY AND SUDDEN-DEATH [J].
NICOD, P ;
POLIKAR, R ;
PETERSON, KL .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (19) :1255-1257
[7]  
PLATIA E, 1987, MANAGEMENT CARDIAC A, P286
[8]   IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - PATIENT SELECTION AND IMPLANTATION PROTOCOL [J].
REID, PR ;
GRIFFITH, LSC ;
MOWER, MM ;
PLATIA, EV ;
WATKINS, L ;
JUANTEGUY, J ;
MIROWSKI, M .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1984, 7 (06) :1338-1344
[9]  
SEILER C, 1989, CIRCULATION S2, V80, P6
[10]   AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - TECHNIQUES OF IMPLANTATION AND RESULTS [J].
THURER, RJ ;
LUCERI, RM ;
BOLOOKI, H .
ANNALS OF THORACIC SURGERY, 1986, 42 (02) :143-147